Evidence map›Paper›PMID 40496668›Full record

ArticleBrain communications2025

Paramagnetic rim lesions are highly specific for multiple sclerosis in real-world data.

Christopher C Hemond, Sathish K Dundamadappa, Mugdha Deshpande, Jonggyu Baek, Robert H Brown, Carolina Ionete, Daniel S Reich

Abstract read
In one paragraph

Article in Brain communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Christopher C HemondDepartment of Neurology, University of Massachusetts Memorial Medical Center, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.ORCID https://orcid.org/0000-0002-2408-4638
Sathish K DundamadappaDepartment of Radiology, University of Massachusetts Memorial Medical Center, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Mugdha DeshpandeDepartment of Neurology, University of Massachusetts Memorial Medical Center, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Jonggyu BaekDepartment of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Robert H BrownDepartment of Neurology, University of Massachusetts Memorial Medical Center, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Carolina IoneteDepartment of Neurology, University of Massachusetts Memorial Medical Center, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Daniel S ReichTranslational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.ORCID https://orcid.org/0000-0002-2628-4334

Funding

MRI Paramagnetic Rim Lesions as Biomarkers and Agents of Neurodegeneration in Multiple SclerosisK23NS126718 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Christopher C. Hemond · 2022 to 2026
$1.0M
NINDS NIH HHS K23 NS126718
6 · The paper itself

Abstract

Paramagnetic rim lesions (PRLs) are an emerging biomarker for multiple sclerosis representing chronic, low-grade intraparenchymal brain inflammation. In addition to associating with greater disease severity, PRLs may be diagnostically supportive. Our aim in this study was to determine PRL specificity and sensitivity for discriminating multiple sclerosis from its diagnostic mimics using real-world clinical diagnostic and imaging data. This is a retrospective, cross-sectional analysis of a longitudinal cohort of patients with prospectively collected observational data. Patients were included if they underwent clinical evaluation in our academic neuroimmunology centre and had an available MRI scan from the same clinical 3-T magnet that included a T2*-weighted sequence with susceptibility post-processing (Susceptibility Weighted ANgiography protocol, General Electric). Susceptibility imaging-derived filtered phase maps and corresponding T2-fluid attenuated inversion recovery images were manually reviewed to determine PRLs. PRLs were categorized as 'definite', 'probable' or 'possible' based on modified, recent consensus criteria. We hypothesized that PRLs would convey a high specificity to discriminate multiple sclerosis from its MRI mimics. Five hundred seventy-four patients were evaluated in total: 473 with multiple sclerosis, 53 with non-inflammatory neurological disease and 48 with other inflammatory neurological disease. Identification of 'definite' or 'probable' PRL provided a specificity of 98% to discriminate multiple sclerosis from non-inflammatory neurological disease and other inflammatory neurological disease; sensitivity was 36%. Interrater agreement was almost perfect for definite/probable identification at a subject level. PRLs convey high specificity for multiple sclerosis and can aid in the diagnostic evaluation. Modest sensitivity limits their use as single diagnostic indicators. Including lesions with lower confidence ('possible') rapidly erodes specificity and should be interpreted with caution given the potential harms associated with misdiagnosis.

Indexed as

diagnosismimicsmultiple sclerosisparamagnetic rim lesionspecificity

Identifiers

PMID40496668
PMCPMC12150028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.